Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Rite Aid Class Action: Levi & Korsinsky Reminds Rite Aid Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 19, 2022 - RAD

New York, New York--(Newsfile Corp. - October 27, 2022) - Levi & Korsinsky, LLP notifies investors in Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD) of a class action securities lawsuit.

The lawsuit on behalf of Rite Aid investors has been commenced in the the United States District Court for the Eastern District of Pennsylvania. Affected investors purchased or otherwise acquired certain Rite Aid Corporation securities between April 14, 2022 and September 28, 2022. Follow the link below to get more information and be contacted by a member of our team:

https://www.zlk.com/pslra-1/rite-aid-lawsuit-loss-submission-form?prid=33096&wire=5

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7091/142155_937116_logo.jpg

Rite Aid Corporation NEWS - RAD NEWS

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) despite representations to the contrary, the number of new members that the Elixir pharmacy benefit management services business was adding during the selling season ending on January 1, 2023 was in material decline; (ii) Rite Aid was likely to recognize a significant charge for the impairment of goodwill related to Elixir due to a decrease in "lives" covered by Elixir's pharmacy benefit management services business; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT THIS MEANS TO SHAREHOLDERS: If you suffered a loss in Rite Aid during the relevant timeframe, you have until December 19, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. Discuss your rights with our legal team without cost or obligation.

PROTECT YOUR FINANCIAL INTERESTS: Complete this brief submission form https://www.zlk.com/pslra-1/rite-aid-lawsuit-loss-submission-form?prid=33096&wire=5 or call 212-363-7500 to discuss the case.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/142155

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today